# InCrowd

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/incrowd

- Industry: Information Services
- Headquarters: Watertown, US
- Website: www.incrowdnow.com
- Total disclosed funding: $2.5M
- Latest round: Series A (Sep 6, 2012)
- Investors on record: 3

## About

InCrowd, Inc. revolutionizes healthcare market research by utilizing an intelligent platform that connects researchers with diverse healthcare audiences through advanced technology, enhancing data collection and analysis efficiency.Founded in 2010, InCrowd, Inc. is based in Watertown, US, providing innovative solutions for healthcare market research. The company has been involved in 5 deals, with the most recent deal occurring on August 14, 2019, when Saroras Private Capital acquired a majority stake. The company has raised a total of USD 2.17 mn through various funding rounds, with the most recent being a Venture Debt round amounting to USD 0.30 mn. The CEO, Daniel Fitzgerald, continues to lead the company as it evolves in the competitive healthcare research market.InCrowd offers the Konovo Intelligent Platform, formerly known as InCrowd, which streamlines healthcare market research by providing direct access to a wide array of healthcare audiences. The platform incorporates advanced technology, including AI, to facilitate effective data collection and analysis. Its core offerings include the Konovo Intelligent Platform and Custom Audiences, previously known as Survey Healthcare Global, catering to market research agencies, consultancies, and biopharma companies across North America, Europe, and Asia.InCrowd generates its revenue through a subscription-based model and partnerships with market research agencies and biopharma companies. Clients typically subscribe annually to access the Konovo platform and its comprehensive tools for conducting healthcare research. The B2B structure allows agencies and consultancies to leverage InCrowd’s platform to gain insights from engaged healthcare audiences, forming a foundational aspect of their research processes.Following the acquisition in August 2019, InCrowd, Inc. aims to accelerate its strategic growth and enhance its business insights within the life sciences sector. The company is focusing on expanding its global reach and may target new markets in Asia and Europe by 2024. The recent funding will facilitate these initiatives and support the development of upcoming products and enhancements to the existing platform.

## Funding rounds

- Series A, Sep 6, 2012, $2.2M — Nauta Capital
- Seed, Jan 10, 2012, $0.3M — Launchpad Venture Group, Walnut Venture Associates

## Investors

- Launchpad Venture Group (https://capitalatlas.ai/funds/launchpad-venture-group) — Seed
- Walnut Venture Associates (https://capitalatlas.ai/funds/walnut-venture-associates) — Seed
- Nauta Capital (https://capitalatlas.ai/funds/nauta-capital) — Series A